Company
Board Member
2024-06-26–present
Peter Beitsch, MD
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter Beitsch, MD
The company reported in an 8-K filed July 2, 2024 that Peter Beitsch, MD was appointed Director, effective June 26, 2024.
“Peter Beitsch, MD, and Matthew Schwartz, MD joined the Board, effective June 26, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2024-06-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Appointed: Director